Advertisement

Should Quidel Be Your Next Coronavirus Buy?

Should Quidel Be Your Next Coronavirus Buy?

If there's one silver lining to the global coronavirus pandemic it's increased appreciation for quick and easy infectious disease testing. Quidel (NASDAQ: QDEL) was already a leader in the market for point-of-care diagnostic equipment before launching COVID-19 tests. It's hard to know how long to expect explosive demand for coronavirus testing, but it's just a matter of time before Quidel's explosive new revenue stream settles down.